3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
19
Lymphoma, Non-Hodgkin
11
Hodgkin Disease
10
Multiple Myeloma
8
Leukemia, Biphenotypic, Acute
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia
7
Burkitt Lymphoma
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Myeloproliferative Disorders
6
Neuroblastoma
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Anemia, Refractory, with Excess of Blasts
5
Recurrence
4
Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Hematologic Neoplasms
4
Breast Neoplasms
4
Medulloblastoma
3
Lymphoma, T-Cell
3
Lymphoma, Follicular
3
Leukemia, Myelomonocytic, Chronic
3
Sarcoma
2
Rhabdomyosarcoma
2
Primary Myelofibrosis
2
Neoplasms, Plasma Cell
2
Myelodysplastic-Myeloproliferative Diseases
2
Interventions
Cisplatin
26
Paclitaxel
21
pembrolizumab
15
Radiotherapy
13
Carboplatin
13
tislelizumab
12
Fluorouracil
12
Drug Therapy
11
Irinotecan
9
toripalimab
8
Esophagectomy
8
Oxaliplatin
6
Nivolumab
6
Capecitabine
6
Neoadjuvant Therapy
5
Leucovorin
5
Docetaxel
5
lenvatinib
4
camrelizumab
4
Taxes
4
Radiation
4
Levoleucovorin
4
Immune Checkpoint Inhibitors
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
spartalizumab
3
sintilimab
3
apatinib
3
Itraconazole
3
Injections
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Granulocyte Colony-Stimulating Factor
×
1 year
×
Clear all
No trials found.